Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-09-000144
Filing Date
2009-01-22
Accepted
2009-01-21 17:52:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SUCAMPO PHARMACEUTICALS INC suca1231.htm SC 13G/A 33789
  Complete submission text file 0000019617-09-000144.txt   36004
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 38TH FL NEW YORK NY 10017 2122706000
J P MORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Subject) CIK: 0001365216 (see all company filings)

EIN.: 133929237 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83614 | Film No.: 09537406
SIC: 2834 Pharmaceutical Preparations